AN ACT relating to the supervision of pharmacy technicians.
Summary
SB174 revises Kentucky’s pharmacy practice laws to clarify when pharmacy technicians and pharmacy interns may perform certain tasks under pharmacist supervision. The bill expressly allows registered pharmacy technicians and certified pharmacy interns, working under a pharmacist’s supervision, to access a pharmacy’s electronic database to perform order entry, order entry verification, and drug regimen review, so long as the pharmacy has confidentiality safeguards, no data are removed or duplicated, and the pharmacy is located in Kentucky and permitted by the board. It also recognizes that supervision for these activities may be electronic in certain settings.
The bill limits these database-access provisions to non-retail pharmacies that are not open to the public or to hospitals licensed under Kentucky law. It also clarifies that the bill does not authorize final product verification or dispensing from outside a pharmacy, and it does not allow hard-copy prescriptions to be received off-premises. In addition, the bill directs the board not to require immediate pharmacist supervision for technicians stocking, retrieving, or returning inventory, including loading automated dispensing systems with barcode technology. The bill continues to require pharmacy technicians to be registered unless otherwise exempt.
Impact
SB174 would amend KRS 315.020 and related pharmacy practice rules to modernize supervision standards for pharmacy technicians and interns, especially in hospital and closed-door pharmacy settings. It expands the permissible scope of technician and intern work in electronic order processing and inventory handling, while preserving pharmacist oversight and limiting the changes to Kentucky-licensed, board-permitted facilities. The bill would affect pharmacists, pharmacy technicians, pharmacy interns, hospitals, and non-retail pharmacies by reducing the need for immediate in-person supervision for certain administrative and inventory tasks.
Sentiment
Based on the available record, the bill appears to be presented as a technical and operational update to pharmacy practice law rather than a controversial policy shift. There are no recorded committee transcripts or votes in the provided material, so there is no direct evidence of support or opposition from legislators or stakeholders. The text itself suggests an effort to accommodate modern electronic workflows and hospital pharmacy operations while maintaining patient safety and confidentiality protections.
Contention
The main potential points of contention are the expansion of technician and intern responsibilities and the allowance for electronic supervision, which some may view as reducing direct pharmacist oversight. Another possible concern is the use of off-site electronic access to pharmacy databases, even with safeguards, because it raises questions about privacy, security, and the limits of remote work. The bill addresses these concerns by restricting the change to closed-door pharmacies and hospitals, prohibiting off-site final verification and dispensing, and requiring confidentiality controls, indicating that any debate would likely center on balancing efficiency with patient safety and regulatory control.
Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)